- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02271386
Educating and Supporting Primary Care Providers in the Implementation of Evidence-based Practices for ADHD
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19103
- Children's Hospital of Philadelphia
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Primary Subjects: Clinicians
Inclusion Criteria:
- Non-resident clinician (physician or nurse practitioner) at participating site
Exclusion Criteria:
- Residents
Secondary Subjects: Families
Inclusion Criteria:
- Children aged 5-12 years receiving care from a clinician enrolled in the study for ADHD and their parents
Exclusion Criteria:
- Autism spectrum disorder
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention
Clinicians in the intervention arm will receive the three-part intervention (Supporting Practice for ADHD, or SPA) which includes: education about ADHD management and communication training, collaborative consultation, and performance feedback, for the first 8 months of the study.
|
The SPA intervention will last for 8 months for each study arm (first 8 months of the study for the intervention group, last 8 months for the control group). The intervention includes 3 components: 1) a series of web-based educational presentations to provide education to providers about evidence-based practice for managing ADHD and strategies for promoting effective communication with families 2) Collaborative consultation designed to address clinical issues arising in practice will be provided by members of the study team. 3) Providers will be given systematic performance feedback with regard to their use of evidence-based practices for ADHD every 2 months during the 8-month intervention period. |
Other: Control
Clinicians in the control arm will receive no intervention for the first 8 months of the study, then will receive the full SPA intervention for the last 8 months of the study.
|
The SPA intervention will last for 8 months for each study arm (first 8 months of the study for the intervention group, last 8 months for the control group). The intervention includes 3 components: 1) a series of web-based educational presentations to provide education to providers about evidence-based practice for managing ADHD and strategies for promoting effective communication with families 2) Collaborative consultation designed to address clinical issues arising in practice will be provided by members of the study team. 3) Providers will be given systematic performance feedback with regard to their use of evidence-based practices for ADHD every 2 months during the 8-month intervention period. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Patients Who Were Sent the Parents Rating Scale
Time Frame: Baseline Period (8 months)
|
This measure is based on chart review of patients of clinicians in each study arm (up to 4 patients per clinician) and reflects whether there is evidence that a parent rating scale was sent out during the baseline interval
|
Baseline Period (8 months)
|
Number of Patients Whose Parent Rating Scale Was Returned
Time Frame: Baseline Period (8 months)
|
This measure is based on chart review of patients of clinicians in each study arm (up to 4 patients per clinician) and reflects whether there is evidence that a parent rating scale was received by the clinician during the baseline interval
|
Baseline Period (8 months)
|
Number of Patients Who Were Sent the Teacher Rating Scale
Time Frame: Baseline Period (8 months)
|
This measure is based on chart review of patients of clinicians in each study arm (up to 4 patients per clinician) and reflects whether there is evidence that a teacher rating scale was sent out during the baseline interval
|
Baseline Period (8 months)
|
Number of Patients Whose Teacher Rating Scale Was Returned
Time Frame: Baseline Period (8 months)
|
This measure is based on chart review of patients of clinicians in each study arm (up to 4 patients per clinician) and reflects whether there is evidence that a teacher rating scale was received by the clinician during the baseline interval
|
Baseline Period (8 months)
|
Number of Patients Who Were Sent the Parents Rating Scale
Time Frame: Intervention Period (8 months)
|
This measure is based on chart review of patients of clinicians in each study arm (up to 4 patients per clinician) and reflects whether there is evidence that a parent rating scale was sent out during the intervention interval
|
Intervention Period (8 months)
|
Number of Patients Whose Parent Rating Scale Was Returned
Time Frame: Intervention Period (8 months)
|
This measure is based on chart review of patients of clinicians in each study arm (up to 4 patients per clinician) and reflects whether there is evidence that a parent rating scale was received by the clinician during the intervention interval
|
Intervention Period (8 months)
|
Number of Patients Who Were Sent the Teacher Rating Scale
Time Frame: Intervention Period (8 months)
|
This measure is based on chart review of patients of clinicians in each study arm (up to 4 patients per clinician) and reflects whether there is evidence that a teacher rating scale was sent out during the intervention interval
|
Intervention Period (8 months)
|
Number of Patients Whose Teacher Rating Scale Was Returned
Time Frame: Intervention Period (8 months)
|
This measure is based on chart review of patients of clinicians in each study arm (up to 4 patients per clinician) and reflects whether there is evidence that a teacher rating scale was received by the clinician during the intervention interval
|
Intervention Period (8 months)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Patients Who Were Sent the Parent Rating Scale - by MOC Status
Time Frame: Baseline Period (8 months)
|
We calculated the percent of patient charts with evidence that a parent rating scale was sent out during the baseline period, separately for intervention clinicians who did and did not complete Maintenance of Certification (MOC) attestation.
|
Baseline Period (8 months)
|
Number of Patients Whose Parent Rating Scale Was Returned- by MOC Status
Time Frame: Baseline Period (8 months)
|
We calculated the percent of patient charts with evidence that a parent rating scale was received by the clinician/practice during the baseline period, separately for intervention clinicians who did and did not complete Maintenance of Certification (MOC) attestation.
|
Baseline Period (8 months)
|
Number of Patients Who Were Sent the Teacher Rating Scale- by MOC Status
Time Frame: Baseline Period (8 months)
|
We calculated the percent of patient charts with evidence that a teacher rating scale was sent out during the baseline period, separately for intervention clinicians who did and did not complete Maintenance of Certification (MOC) attestation.
|
Baseline Period (8 months)
|
Number of Patients Whose Teacher Rating Scale Was Returned- by MOC Status
Time Frame: Baseline Period (8 months)
|
We calculated the percent of patient charts with evidence that a teacher rating scale was received by the clinician/practice during the baseline period, separately for intervention clinicians who did and did not complete Maintenance of Certification (MOC) attestation.
|
Baseline Period (8 months)
|
Number of Patients Who Were Sent the Parent Rating Scale- by MOC Status
Time Frame: Intervention Period (8 months)
|
We calculated the percent of patient charts with evidence that a parent rating scale was sent out during the intervention period, separately for intervention clinicians who did and did not complete Maintenance of Certification (MOC) attestation.
|
Intervention Period (8 months)
|
Number of Patients Whose Parent Rating Scale Was Returned- by MOC Status
Time Frame: Intervention Period (8 months)
|
We calculated the percent of patient charts with evidence that a parent rating scale was received by the clinician/practice during the intervention period, separately for intervention clinicians who did and did not complete Maintenance of Certification (MOC) attestation.
|
Intervention Period (8 months)
|
Number of Patients Who Were Sent the Teacher Rating Scale- by MOC Status
Time Frame: Intervention Period (8 months)
|
We calculated the percent of patient charts with evidence that a teacher rating scale was sent out during the intervention period, separately for intervention clinicians who did and did not complete Maintenance of Certification (MOC) attestation.
|
Intervention Period (8 months)
|
Number of Patients Whose Teacher Rating Scale Was Returned- by MOC Status
Time Frame: Intervention Period (8 months)
|
We calculated the percent of patient charts with evidence that a teacher rating scale was received by the clinician/practice during the intervention period, separately for intervention clinicians who did and did not complete Maintenance of Certification (MOC) attestation.
|
Intervention Period (8 months)
|
Number of Patients Who Were Sent the Parent Rating Scale- by Feedback Call Participation
Time Frame: Baseline Period (8 months)
|
We calculated the percent of patient charts with evidence that a parent rating scale was sent out during the baseline period, separately for intervention clinicians who did and did not participate in at least one performance feedback call.
|
Baseline Period (8 months)
|
Number of Patients Whose Parent Rating Scale Was Returned- by Feedback Call Participation
Time Frame: Baseline Period (8 months)
|
We calculated the percent of patient charts with evidence that a parent rating scale was received by the clinician/practice during the baseline period, separately for intervention clinicians who did and did not participate in at least one performance feedback call.
|
Baseline Period (8 months)
|
Number of Patients Who Were Sent the Teacher Rating Scale- by Feedback Call Participation
Time Frame: Baseline Period (8 months)
|
We calculated the percent of patient charts with evidence that a teacher rating scale was sent out during the baseline period, separately for intervention clinicians who did and did not participate in at least one performance feedback call.
|
Baseline Period (8 months)
|
Number of Patients Whose Teacher Rating Scale Was Returned- by Feedback Call Participation
Time Frame: Baseline Period (8 months)
|
We calculated the percent of patient charts with evidence that a teacher rating scale was received by the clinician/practice during the baseline period, separately for intervention clinicians who did and did not participate in at least one performance feedback call.
|
Baseline Period (8 months)
|
Number of Patients Who Were Sent the Parent Rating Scale- by Feedback Call Participation
Time Frame: Intervention Period (8 months)
|
We calculated the percent of patient charts with evidence that a parent rating scale was sent out during the intervention period, separately for intervention clinicians who did and did not participate in at least one performance feedback call.
|
Intervention Period (8 months)
|
Number of Patients Whose Parent Rating Scale Was Returned- by Feedback Call Participation
Time Frame: Intervention Period (8 months)
|
We calculated the percent of patient charts with evidence that a parent rating scale was received by the clinician/practice during the intervention period, separately for intervention clinicians who did and did not participate in at least one performance feedback call.
|
Intervention Period (8 months)
|
Number of Patients Who Were Sent the Teacher Rating Scale- by Feedback Call Participation
Time Frame: Intervention Period (8 months)
|
We calculated the percent of patient charts with evidence that a teacher rating scale was sent out during the intervention period, separately for intervention clinicians who did and did not participate in at least one performance feedback call.
|
Intervention Period (8 months)
|
Number of Patients Whose Teacher Rating Scale Was Returned- by Feedback Call Participation
Time Frame: Intervention Period (8 months)
|
We calculated the percent of patient charts with evidence that a teacher rating scale was received by the clinician/practice during the intervention period, separately for intervention clinicians who did and did not participate in at least one performance feedback call.
|
Intervention Period (8 months)
|
Implementation Outcome: Number of Clinicians Who Completed All 3 Educational Presentations
Time Frame: Intervention Period (8 months)
|
We assessed the proportion of clinicians randomized to the intervention group that completed all 3 educational presentations.
|
Intervention Period (8 months)
|
Implementation Outcome: Number of Clinicians Who Used the Collaborative Consultation Component
Time Frame: Intervention Period (8 months)
|
We calculated the proportion of clinicians in the intervention group that posted in the online networking site which was used to facilitate collaborative consultation.
|
Intervention Period (8 months)
|
Implementation Outcome: Number of Clinicians Who Participated in at Least One Performance Feedback Call
Time Frame: Intervention Period (8 months)
|
We calculated the proportion of clinicians in the intervention group who participated in at least one of the four performance feedback calls that were held during the study period.
|
Intervention Period (8 months)
|
Implementation Outcome: Number of Clinicians Who Participated in All Intervention Components and Attested to Fulfilling MOC Requirements
Time Frame: Intervention Period (8 months)
|
We calculated the proportion of clinicians in the intervention group who completed all components of the intervention and attested to fulfilling MOC requirements.
|
Intervention Period (8 months)
|
Collaborators and Investigators
Investigators
- Principal Investigator: Thomas Power, PhD, Children's Hospital of Philadelphia
- Principal Investigator: Alexander G Fiks, MD, MSCE, Children's Hospital of Philadelphia
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 14-011189
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Attention Deficit Hyperactivity Disorder
-
Cingulate TherapeuticsRecruitingPhase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301ADHD | Attention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit HyperactivityUnited States
-
Ornit CohenUnknownAttention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | Attention Deficit Disorder | Attention Deficit Disorders With Hyperactivity | Attention Deficit Hyperactivity DisordersIsrael
-
Cingulate TherapeuticsPremier Research Group plcActive, not recruitingADHD | Attention Deficit Hyperactivity Disorder | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit HyperactivityUnited States
-
Children's National Research InstituteRecruitingADHD | Attention Deficit Hyperactivity Disorder | Attention-Deficit Hyperactivity Disorder | Attention Deficit Disorder | ADD | ADHD Predominantly Inattentive Type | ADHD - Combined Type | ADHD, Predominantly Hyperactive - Impulsive | Attention-Deficit Disorder in Adolescence | Attention-Deficit Hyperactivity...United States
-
Fondation LenvalCompletedAttention Deficit Disorder With Hyperactivity | Attention Deficit Disorder Without HyperactivityFrance
-
University Hospital Bispebjerg and FrederiksbergMental Health Services in the Capital Region, DenmarkRecruitingSleep Disturbance | Neurodevelopmental Disorders | Attention Deficit Hyperactivity Disorder | Attention Deficit Disorder | Attention-Deficit Hyperactivity Disorder, Unspecified Type | Attention-deficit Hyperactivity | Hyperkinetic Conduct DisorderDenmark
-
Corium, Inc.Worldwide Clinical Trials; Premier Research Group plc; Almac; Prometrika, LLCRecruitingAttention Deficit/Hyperactivity DisorderUnited States
-
Corium, Inc.Premier Research Group plc; Almac; Prometrika, LLCRecruitingAttention Deficit/Hyperactivity DisorderUnited States
-
Massachusetts General HospitalShire Human Genetic Therapies, Inc.Active, not recruitingAttention Deficit/Hyperactivity DisorderUnited States
-
Atatürk UniversityCompletedAttention-deficit/Hyperactivity DisorderTurkey
Clinical Trials on Supporting Practice for ADHD (SPA)
-
Medical Research Council, South AfricaCompletedPartner of Victim of Physical Abuse
-
University of CopenhagenResearch Unit for General Practice, Aarhus University; Slagelse Hospital; Research... and other collaboratorsNot yet recruitingMultimorbidityDenmark
-
King's College LondonSouth London and Maudsley NHS Foundation TrustNot yet recruiting
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompleted
-
Universitaire Ziekenhuizen KU LeuvenKU Leuven; Research Foundation FlandersActive, not recruiting
-
Dalhousie UniversityCompletedAttention Deficit Hyperactivity Disorder (ADHD)Canada
-
University of IcelandActive, not recruitingAttention-deficit HyperactivityIceland
-
Temple UniversityNational Institute of Mental Health (NIMH); Brown University; University of Illinois... and other collaboratorsCompletedAnxiety DisordersUnited States
-
Children's Hospital Medical Center, CincinnatiCompletedAttention Deficit Hyperactivity DisorderUnited States
-
University of BergenHaukeland University HospitalRecruitingAttention Deficit Hyperactivity DisorderNorway